Cargando…
Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity
BACKGROUND: SARS-CoV-2 uses the angiotensin-converting enzyme 2 (ACE2) and neuropilin-1 (NRP1) receptors for entry into cells, and the serine protease TMPRSS2 for S protein priming. Inhibition of protease activity or the engagement with ACE2 and NRP1 receptors has been shown to be an effective strat...
Autores principales: | Saiz, Maria Laura, De Diego, Marta L., López-García, Darío, Corte-Iglesias, Viviana, Baragaño Raneros, Aroa, Astola, Ivan, Asensi, Victor, López-Larrea, Carlos, Suarez-Alvarez, Beatriz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504098/ https://www.ncbi.nlm.nih.gov/pubmed/34635175 http://dx.doi.org/10.1186/s13148-021-01168-5 |
Ejemplares similares
-
Correction to: Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS‑CoV‑2 infectivity
por: Saiz, Maria Laura, et al.
Publicado: (2021) -
Epigenetic modulation of the immune function: A potential target for tolerance
por: Suárez-Álvarez, Beatriz, et al.
Publicado: (2013) -
Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention
por: Baragaño Raneros, Aroa, et al.
Publicado: (2014) -
An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes
por: Raneros, Aroa Baragaño, et al.
Publicado: (2021) -
Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia
por: Baragaño Raneros, Aroa, et al.
Publicado: (2021)